ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Neurochem - Common Shares (MM)

Neurochem - Common Shares (MM) (NRMX)

2,00
0,00
(0,00%)
Geschlossen 12 Dezember 10:00PM
2,00
0,00
( 0,00% )
Vor Marktöffnung: 1:00AM

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Current Price
2,00
Gebot
0,00
Fragen
0,00
Volumen
-
0,00 Tagesbereich 0,00
0,00 52-Wochen-Bereich 0,00
Handelsende
2,00
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
-
Durchschnittliches Volumen (3 Mio.)
-
Finanzvolumen
-
VWAP
-

NRMX Neueste Nachrichten

At Annual and Special Meeting of Shareholders - Neurochem to officially adopt new name - BELLUS Health - And to provide update o

Neurochem Annual and Special Meeting web cast live LAVAL, QC, April 15 /PRNewswire-FirstCall/ -- At the Annual and Special meeting of Neurochem Inc. (NASDAQ: NRMX; TSX: NRM), shareholders will...

Media advisory - Neurochem's Annual and Special Meeting of Shareholders April 15, 2008

LAVAL, QC, April 11 /PRNewswire-FirstCall/ -- Dr. Francesco Bellini, Chairman, President and Chief Executive Officer of Neurochem Inc., invites the news media to the Annual and Special Meeting...

Neurochem Annual and Special Meeting of shareholders

Neurochem will host a live Web conference on Tuesday, April 15, 2008, at 10:00 AM ET LAVAL, QC, April 11 /PRNewswire-FirstCall/ -- Dr. Francesco Bellini, Chairman, President and Chief...

Neurochem moves eprodisate (KIACTA(TM)) drug development program forward for Amyloid A amyloidosis

ECUBLENS, SWITZERLAND, March 13 /PRNewswire-FirstCall/ -- Neurochem (International) Limited (Neurochem), a wholly-owned subsidiary of Neurochem Inc. (NASDAQ: NRMX; TSX: NRM), announces that the...

Neurochem announces departure of two members of management team

LAVAL, QC, Feb. 21 /PRNewswire-FirstCall/ -- In light of Neurochem Inc.'s (NASDAQ: NRMX; TSX: NRM) new strategic direction, the Company announces the departure, effective February 21, 2008, of...

Neurochem reports results for fourth quarter and fiscal year 2007 and important advances on corporate objectives

Neurochem will host a conference call Thursday, February 21, 2008, at 8:30 A.M. ET. LAVAL, QC, Feb. 20 /PRNewswire-FirstCall/ -- Neurochem Inc. (NASDAQ: NRMX; TSX: NRM) reports results for the...

/C O R R E C T I O N from source -- Neurochem Inc./

In MO389 sent on Monday February 11 2008 at 10:45e, an error occured in the link to the Web cast in the second paragraph. The correct link should have read LAVAL, QC, Feb. 11...

Neurochem to present at 2008 BIO CEO & Investor Conference - Presentation will be Web cast live

LAVAL, QC, Feb. 11 /PRNewswire-FirstCall/ -- Neurochem Inc. (NASDAQ: NRMX; TSX: NRM) announces today that on Wednesday, February 13, 2008, Dr. Francesco Bellini, Neurochem's Chairman, President...

Neurochem appoints Mr. Gary Schmid as CEO of new nutraceutical business

LAVAL, QC, Jan. 30 /PRNewswire-FirstCall/ -- Neurochem Inc. (NASDAQ: NRMX; TSX: NRM) is pleased to announce that Mr. Gary Schmid will join Neurochem, effective February 4, 2008, and will serve...

Neurochem to present at JPMorgan Healthcare Conference

LAVAL, QC, Jan. 3 /PRNewswire-FirstCall/ -- Neurochem Inc. (NASDAQ: NRMX; TSX: NRM) announces today that on Thursday, January 10, 2008, Dr. Francesco Bellini, Chairman, President and CEO, will...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
PALIPalisade Bio Inc
US$ 3,20
(128,57%)
20,1M
SYTASiyata Mobile Inc
US$ 1,05
(40,37%)
12,24M
TRVITrevi Therapeutics Inc
US$ 3,40
(36,55%)
2,47M
ZENAZenaTech Inc
US$ 7,46
(31,11%)
3,6M
ATLNAtlantic International Corporation
US$ 7,00
(22,74%)
1
KROSKeros Therapeutics Inc
US$ 18,78
(-72,64%)
609,66k
SPGCSacks Parente Golf Inc
US$ 0,50
(-64,29%)
163,73k
PNBKPatriot National Bancorp Inc
US$ 1,08
(-58,78%)
16
AVGRAvinger Inc
US$ 0,441
(-46,22%)
87,3k
HEPAHepion Pharmaceuticals Inc
US$ 0,36
(-38,46%)
1
PALIPalisade Bio Inc
US$ 3,20
(128,57%)
20,1M
CDTConduit Pharmaceuticals Inc
US$ 0,1012
(14,61%)
14,2M
AMPGAmplitech Group Inc
US$ 2,20
(13,99%)
13,48M
SYTASiyata Mobile Inc
US$ 1,05
(40,37%)
12,24M
LAESSEALSQ Corporation
US$ 1,245
(8,26%)
8,74M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock